海康威视(002415.SZ):龚虹嘉已通过大宗交易减持7600万股
格隆汇 11 月 6日丨海康威视(002415.SZ)公布,公司于2020年9月3日收到股东龚虹嘉出具的《龚虹嘉关于减持计划实施完毕的告知函》,龚虹嘉通过竞价交易共计减持公司股份9344.8486万股,占公司总股本的0.99998%。
公司于2020年11月6日收到股东龚虹嘉通知,龚虹嘉通过大宗交易共计减持公司股份7600万股,占公司总股本的0.8133%。
综上,自新《证券法》第六十三条颁布以来,龚虹嘉于2020年8月7日至2020年11月5日期间,通过证券交易所的证券交易减持公司股份达到1.81%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.